Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Itziar San-José"'
Autor:
Virginia Pérez-Grijalba, Javier Arbizu, Judith Romero, Elena Prieto, Pedro Pesini, Leticia Sarasa, Fernando Guillen, Inmaculada Monleón, Itziar San-José, Pablo Martínez-Lage, Josep Munuera, Isabel Hernández, Mar Buendía, Oscar Sotolongo-Grau, Montserrat Alegret, Agustín Ruiz, Lluis Tárraga, Mercè Boada, Manuel Sarasa, The AB255 Study Group
Publikováno v:
Alzheimer’s Research & Therapy, Vol 11, Iss 1, Pp 1-9 (2019)
Abstract Background To facilitate population screening and clinical trials of disease-modifying therapies for Alzheimer’s disease, supportive biomarker information is necessary. This study was aimed to investigate the association of plasma amyloid-
Externí odkaz:
https://doaj.org/article/8ea557f727a645db9b4c9c8e9f242844
Autor:
Ana-María Lacosta, María Pascual-Lucas, Pedro Pesini, Diego Casabona, Virginia Pérez-Grijalba, Iván Marcos-Campos, Leticia Sarasa, Jesus Canudas, Hassnae Badi, Inmaculada Monleón, Itziar San-José, Josep Munuera, Octavio Rodríguez-Gómez, Carla Abdelnour, Asunción Lafuente, Mar Buendía, Mercè Boada, Lluis Tárraga, Agustín Ruiz, Manuel Sarasa
Publikováno v:
Alzheimer’s Research & Therapy, Vol 10, Iss 1, Pp 1-13 (2018)
Abstract Background Immunotherapy targeting the amyloid-β (Aβ) peptide is a promising strategy for the treatment of Alzheimer’s disease (AD); however, none of the active or passive vaccines tested have been demonstrated to be effective to date. W
Externí odkaz:
https://doaj.org/article/1030c599a5ae4b4d8f002a265d9af497
Autor:
Pedro Pesini, Virginia Pérez-Grijalba, Inmaculada Monleón, Mercè Boada, Lluís Tárraga, Pablo Martínez-Lage, Itziar San-José, Manuel Sarasa
Publikováno v:
International Journal of Alzheimer's Disease, Vol 2012 (2012)
The present study was aimed at assessing the capability of Aβ1-40 and Aβ1-42 levels in undiluted plasma (UP), diluted plasma (DP), and cell bound (CB) to distinguish between early stages of Alzheimer's disease (AD), amnesic mild cognitive impairmen
Externí odkaz:
https://doaj.org/article/8f08842b5193475fa2bf9c3cda2dfb8b
Autor:
Manuel Sarasa, Mar Buendía, Pablo Martinez-Lage, Mercè Boada, Oscar Sotolongo-Grau, Judith Romero, Inmaculada Monleón, Josep Munuera, Montserrat Alegret, Javier Arbizu, Isabel Hernández, Elena Prieto, Lluís Tárraga, Agustín Ruiz, Virginia Pérez-Grijalba, Fernando Guillen, Pedro Pesini, Itziar San-José, Leticia Sarasa
Publikováno v:
Alzheimer’s Research & Therapy, Vol 11, Iss 1, Pp 1-9 (2019)
Dadun. Depósito Académico Digital de la Universidad de Navarra
Consejo Superior de Investigaciones Científicas (CSIC)
Alzheimer's Research & Therapy
ALZHEIMERS RESEARCH & THERAPY
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
Dadun. Depósito Académico Digital de la Universidad de Navarra
Consejo Superior de Investigaciones Científicas (CSIC)
Alzheimer's Research & Therapy
ALZHEIMERS RESEARCH & THERAPY
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
BackgroundTo facilitate population screening and clinical trials of disease-modifying therapies for Alzheimer’s disease, supportive biomarker information is necessary. This study was aimed to investigate the association of plasma amyloid-beta (Aβ)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48579370ed8e0d9131471b3ddaa53fbe
https://doaj.org/article/8ea557f727a645db9b4c9c8e9f242844
https://doaj.org/article/8ea557f727a645db9b4c9c8e9f242844
Autor:
Inmaculada Monleón, L. Tárraga, Virginia Pérez-Grijalba, Leticia Sarasa, Pablo Martinez-Lage, Javier Arbizu, Agustín Ruiz, Judith Romero, Josep Munuera, Pedro Pesini, Itziar San-José, Manuel Sarasa, Mercè Boada
Publikováno v:
The Journal Of Prevention of Alzheimer's Disease. :1-8
Background: Easily accessible biomarkers are needed for the early identification of individuals at risk of developing Alzheimer’s disease (AD) in large population screening strategies. Objectives: This study evaluated the potential of plasma β-amy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::803131e4ee98f05ea67f375824500924
https://doi.org/10.14283/jpad.2018.41
https://doi.org/10.14283/jpad.2018.41
Autor:
Mar Buendía, Leticia Sarasa, Octavio Rodriguez-Gomez, Inmaculada Monleón, Carla Abdelnour, Virginia Pérez-Grijalba, Josep Munuera, María Pascual-Lucas, Hassnae Badi, Mercè Boada, Iván Marcos-Campos, Ana-María Lacosta, Pedro Pesini, Diego Casabona, Lluís Tárraga, Asunción Lafuente, Itziar San-José, Manuel Sarasa, Jesús Canudas, Agustín Ruiz
Publikováno v:
Alzheimer’s Research & Therapy, Vol 10, Iss 1, Pp 1-13 (2018)
Background Immunotherapy targeting the amyloid-β (Aβ) peptide is a promising strategy for the treatment of Alzheimer’s disease (AD); however, none of the active or passive vaccines tested have been demonstrated to be effective to date. We have de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43050109efbefedc7191fcc3217fd290
http://link.springer.com/article/10.1186/s13195-018-0340-8
http://link.springer.com/article/10.1186/s13195-018-0340-8
Autor:
Ana-María, Lacosta, María, Pascual-Lucas, Pedro, Pesini, Diego, Casabona, Virginia, Pérez-Grijalba, Iván, Marcos-Campos, Leticia, Sarasa, Jesus, Canudas, Hassnae, Badi, Inmaculada, Monleón, Itziar, San-José, Josep, Munuera, Octavio, Rodríguez-Gómez, Carla, Abdelnour, Asunción, Lafuente, Mar, Buendía, Mercè, Boada, Lluis, Tárraga, Agustín, Ruiz, Manuel, Sarasa
Publikováno v:
Alzheimer's Research & Therapy
Background Immunotherapy targeting the amyloid-β (Aβ) peptide is a promising strategy for the treatment of Alzheimer’s disease (AD); however, none of the active or passive vaccines tested have been demonstrated to be effective to date. We have de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::70a100f41e250fcb692e4ba06dc91dd5
https://pubmed.ncbi.nlm.nih.gov/29378651
https://pubmed.ncbi.nlm.nih.gov/29378651
Autor:
Lluís Tárraga, Laura Núñez, Leticia Sarasa, Virginia Pérez-Grijalba, Pedro Pesini, Agustín Ruiz, Manuel Sarasa, I. Marcos, Ana M. Lacosta, Mercè Boada, Itziar San José
Publikováno v:
Alzheimer's & Dementia. 12
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7385d8189242dd8736d5d1e97331ab0d
https://doi.org/10.1016/j.jalz.2016.06.348
https://doi.org/10.1016/j.jalz.2016.06.348
Autor:
Lluís Tárraga, Monserrat Alegret, Isabel Hernández, Pedro Pesini, Asunción Lafuente, Manuel Sarasa, Oscar Sotolongo-Grau, Sergi Valero, Ana Espinosa, Mercè Boada, Marta Ibarria, Itziar San José, Susana Ruiz, Agustín Ruiz, Mar Buendía
Publikováno v:
Alzheimer's & Dementia. 11
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7aa357ef3fd48d693ae3310c3e31ed78
https://doi.org/10.1016/j.jalz.2015.06.1567
https://doi.org/10.1016/j.jalz.2015.06.1567
Autor:
Miguel Angel Tejero, Itziar San José, Joan Giménez, Virginia Pérez-Grijalba, Lluís Tárraga, Mercè Boada, Sergi Valero, Mar Buendía, Marta Ibarria, Pedro Pesini, Asunción Lafuente, Oscar Sotolongo-Grau, Manuel Sarasa, Agustín Ruiz, Isabel Hernández
Publikováno v:
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Alzheimer's Research & Therapy
Universitat Autònoma de Barcelona
Alzheimer's Research & Therapy
Introduction The identification of early, preferably presymptomatic, biomarkers and true etiologic factors for Alzheimer’s disease (AD) is the first step toward establishing effective primary and secondary prevention programs. Consequently, the sea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a243db7f31c749ae66ae804e365e29ea
https://doi.org/10.1186/s13195-014-0056-3
https://doi.org/10.1186/s13195-014-0056-3